282 related articles for article (PubMed ID: 15385731)
1. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.
Berhane K; Karim R; Cohen MH; Masri-Lavine L; Young M; Anastos K; Augenbraun M; Watts DH; Levine AM
J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1245-52. PubMed ID: 15385731
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study.
Levine AM; Berhane K; Masri-Lavine L; Sanchez M; Young M; Augenbraun M; Cohen M; Anastos K; Newman M; Gange SJ; Watts H
J Acquir Immune Defic Syndr; 2001 Jan; 26(1):28-35. PubMed ID: 11176266
[TBL] [Abstract][Full Text] [Related]
3. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study.
Anastos K; Kalish LA; Hessol N; Weiser B; Melnick S; Burns D; Delapenha R; DeHovitz J; Cohen M; Meyer W; Bremer J; Kovacs A
AIDS; 1999 Sep; 13(13):1717-26. PubMed ID: 10509574
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
Mildvan D; Creagh T; Leitz G;
Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
[TBL] [Abstract][Full Text] [Related]
5. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.
Anastos K; Barrón Y; Cohen MH; Greenblatt RM; Minkoff H; Levine A; Young M; Gange SJ
Ann Intern Med; 2004 Feb; 140(4):256-64. PubMed ID: 14970148
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women.
Vaamonde CM; Hoover DR; Anastos K; Tan T; Shi Q; Gao W; Kovacs A; Cohen M; DeHovitz J; Glesby MJ
AIDS Res Hum Retroviruses; 2006 Mar; 22(3):222-31. PubMed ID: 16545008
[TBL] [Abstract][Full Text] [Related]
7. Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model.
Chu H; Gange SJ; Yamashita TE; Hoover DR; Chmiel JS; Margolick JB; Jacobson LP
Am J Epidemiol; 2005 Oct; 162(8):787-97. PubMed ID: 16135508
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
9. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
[TBL] [Abstract][Full Text] [Related]
10. Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States.
Melekhin VV; Shepherd BE; Jenkins CA; Stinnette SE; Rebeiro PF; Bebawy SS; Rasbach DA; Hulgan T; Sterling TR
AIDS Patient Care STDS; 2010 May; 24(5):279-86. PubMed ID: 20438375
[TBL] [Abstract][Full Text] [Related]
11. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
[TBL] [Abstract][Full Text] [Related]
12. Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).
Jaén A; Esteve A; Miró JM; Tural C; Montoliu A; Ferrer E; Riera M; Segura F; Force L; Sued O; Vilaró J; Garcia I; Masabeu A; Altès J; Coltet B; Podzamczer D; Murillas J; Navarro G; Gatell JM; Casabona J;
J Acquir Immune Defic Syndr; 2008 Feb; 47(2):212-20. PubMed ID: 18297762
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster in women with and at risk for HIV: data from the Women's Interagency HIV Study.
Glesby MJ; Hoover DR; Tan T; Shi Q; Gao W; French AL; Maurer T; Young M; Dehovitz J; Ru J; Anastos K
J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1604-9. PubMed ID: 15577417
[TBL] [Abstract][Full Text] [Related]
14. Impaired Hematologic Status in Relation to Clinical Outcomes among HIV-Infected Adults from Uganda: A Prospective Cohort Study.
Ezeamama AE; Guwatudde D; Sikorskii A; Kabagambe EK; Spelts R; Vahey G; Fenton JI; Fawzi WW
Nutrients; 2018 Apr; 10(4):. PubMed ID: 29649107
[TBL] [Abstract][Full Text] [Related]
15. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
[TBL] [Abstract][Full Text] [Related]
16. Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy.
Semba RD; Shah N; Vlahov D
J Acquir Immune Defic Syndr; 2001 Apr; 26(4):315-9. PubMed ID: 11317071
[TBL] [Abstract][Full Text] [Related]
17. The CD4 slope can be a predictor of immunologic recovery in advanced HIV patients: a case-control study.
Kim KH; Yi J; Lee SH
Korean J Intern Med; 2015 Sep; 30(5):705-13. PubMed ID: 26354065
[TBL] [Abstract][Full Text] [Related]
18. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
[TBL] [Abstract][Full Text] [Related]
19. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
20. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort.
Wamalwa DC; Obimbo EM; Farquhar C; Richardson BA; Mbori-Ngacha DA; Inwani I; Benki-Nugent S; John-Stewart G
BMC Pediatr; 2010 May; 10():33. PubMed ID: 20482796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
